GlassScriptPhysician profile
Alison M Joseph
NPI 1366603714
$6,220.15
in general payments reported to CMS, 2019-2025
14 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $759 · 2021: $1,288 · 2022: $3,553 · 2023: $29.66 · 2024: $293 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $3,682.53 | 2020-2022 | |
| Arthrex, INC. | $1,567.68 | 2022 | |
| Stryker Corporation | $329.23 | 2021-2025 | Augment Injectable |
| Treace Medical Concepts, INC. | $199.73 | 2023-2024 | |
| Horizon Therapeutics Plc | $125.00 | 2019 | |
| Smith+Nephew, INC. | $86.77 | 2019-2025 | Collagenase Santyl |
| Paragon 28, INC. | $75.46 | 2023-2024 | Precision Mis Bunion, Mtp |
| Bone Support INC. | $34.91 | 2024 | Ceramentbone Void Filler, Cerament G |
| Medline Industries LP | $23.44 | 2022 | |
| Cashflow Solutions, LLC | $22.02 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Convatec INC. | $21.33 | 2025 | |
| Integra Lifesciences Corporation | $20.34 | 2022 | |
| Koya Medical, INC. | $18.71 | 2025 | Dayspring, Koya Medical |
| Omeza LLC | $13.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.